Member Info for Dingodog1

Is there a concern that with the UK gov looking to lift all covid restrictions, as with other countries, that complacentcy will set in and vigilence and thus desire for monitoring will take a back seat?

If covid becomes, in effect, "the common cold", will employers, governments and civilians care if they have covid? And if no one cares about covid will the desire for PD reduce?

I know DVRG offers lots more than covid detection, but it concerns me that the demand will take a hit if the world decides that covid isnt worth worrying about.

I would like to think the world will want a pandemic surveilance system in place, but wanting and paying for it are two completely different things.

I welcome views on this, perhaps even from GB himself.

You responded just before i did T.Rat :-)

The Dell wyse 5070 is a commercially available unit. It isnt specific PD/DVRG tech. Its use in this image doesn't, to me, suggest this is necessarily anything to do with our partnership, at least not on a bespoke tech/infastructure level.

It is, of course, possible that Dell have chucked a load of these units at us for a reduced fee/free as part of the partnership

https://www.laptopsdirect.co.uk/dell-wyse-5070-intel-pentium-silver-j5005-8gb-32gb-ssd-windows-10-iot-ente-xwnyk/version.asp?utm_source=google&utm_medium=Free%20Listings&utm_campaign=shopping%20feed&utm_content=free%20google%20shopping%20clicks&refsource=ldadwords&mkwid=ssrZ707bb_dm&pcrid=539341816318&product=XWNYK&pgrid=125353698145&ptaid=pla-1402230666427&channel=googlesearch&gclid=Cj0KCQiA0p2QBhDvARIsAACSOOMJGLJ5v7CtR_bFwCsI5zDK0_QXinNgPzpg_7qp0hNVqVQRtaYmUKMaAh9UEALw_wcB

Signed

If such a deal would require, say, 300 PD units installed and raring to go i think it would cause an issue for DVRG today. Manual samples and people down man holes is expensive, but quite easy to provide. You need labour that is willing to take said samples and deliver them to a facility. Job done.

DVRG is offering an automated technological alternative. The units need to physically exist, on the scale required, before they can be deployed. Manufacture of parts to the scale required is holding back the larger contracts imo.

I could be wrong. Perhaps PD is considered too expensive etc, but i trust GB is speaking to the right people and that we will see movement once CR is signed off

Continued... (sausage fingers and phone!)

dependent on the CR deal. Once this is all in place DVRG can go for the bigger contracts for many millions and actually have the internal supply lines to back it up

DVRG cant produce 200 PD units a month yet. It will have that capacity soon, and at that point i expect DVRG to nail down some sizable contracts once they can deliver on them.

All imo

My view is that DVRG cannot be awarded contracts until they have the infrastructure to deliver on said contracts. This infrastructure will likely be dependent on

MODE had/have great ideas but they have tried to apply too much innovation before they got the business off the ground.

Replicate e-toro, binance etc, but with regulation, and MODE will do very well, even if not really bringing anything new to the table.

Once that core is established THEN they can innovate, when they have solid turnover coming in that can cover costs.

At this point being a copycat platform would bring a smile to the face of the (1 year) long suffering shareholders

I was thinking the same goolang. MODE prospers when there is BTC volatility. And that free bitcoin competition may conclude with a, relatively, cheap bitcoin cost for MODE

BTC was $66k or so back in November. $33k as things stand is very timely when giving one away!

(Not so timely when you hold BTC as an asset class)

There are only 6 more trading days in January before month one of 2022 is over. In this time DVRG may have recorded £1-2m in revenue.

I wonder what is resulting in the delay of the 2022 revenue expectation. Perhaps DVRG are waiting for a few things to become clearer before finalising. Perhaps CR is close. It would heavily impact revenue imo. Or maybe they are waiting for early uptake of STC medical or traction of STC in the US. Either way, hopefully we hear something soon! :-)

The valuable database grows and the STC name spreads. Important to keep this in mind for anyone who sees "given away" or "free trial" and shudders

I would hope that the business would cash in the BTC before considering a raise. The latest BTC was purchased via the funds of an earlier raise, and so some of that dilutive fund raise went into an investment class which has hopefully grown. With this in mind MODE owe it to the shareholders to stave off further dilution until all cash and cash equivalent assets have been exhausted. Keeping the BTC reserve but raising cash via dilution would be a stupid business decision.

If i couldnt afford my mortgage but had BTC in the bank i would certainly cash in the BTC to cover my bills instead of giving away part of my property. MODE needs to have the same approach.

The original £24m came from July/August 2021. We didn't hear about MW mobile services until late 2021

So, it is possible that the £24m related to existing operations as at July/August (ie, STC, labskin, MW). However, the brokers know a lot about what is going on in the background, more than us that is for sure, so perhaps this was a factor. STC medical is also a new revenue stream

We shall await the DVRG forecast and see what GB provides us at that time

All time low. Surely £15m is ridiculously cheap for what MODE has to offer. The BTC trading platform with FCA regulation alone must be worth more.

Clearly sentiment here is rock bottom and the company only have themselves to blame. As a shareholder it is very much a case of bottom drawer time. Hopefully 2022 sees a return to the 40's and above. Very disappointing first 15 months on the market for MODE

I think the company's main focus has been building the merchant arm of the business. This has not worked well so far. The boots/homebase/ocado debacle has crashed the SP to current levels.

The best decision they could make now is to focus on adding new crypto currencies. Build up a core following and build the SP with us focusing on replicating the big boys and let the merchant arm tick over in the background.

The MODE SP was around 50-60p before we even knew of the merchant offering plans. The merchant side show has very much killed the SP following the early optimism, imo

And good find Ragnar!

@GB, sounds like we have competition in Italy when this "tool" is ready in 2 or 3 months.

Unless...

There has quite clearly been an over reaction to the RNS, and in the wrong direction. The news regarding STC medical, and progress elsewhere, was very positive. Orders exceeded £10m but due to staff shortages, due to covid, DVRG could not deliver those orders when expected (very understandable). So, eventual turnover came in £670k under the target. Really nothing major under the circumstances and the orders had been received.

That £670k missed turnover wiped about £5m off the MCAP. That is a multiple of 7x to turnover.

If this is how the market correlate turnover to MCAP does that mean if DVRG deliver £24m in 2022 that the MCAP will be £168m? Answer: Unlikely. And thus over reaction to the RNS. Imo

£9.33m is slightly less than the targeted £10m, but the reasons for this (covid absences of staff) are understandable. It looks like around £1m or so has been pushed back in 2022, which gives us an early head start.

I am satisfied with this RNS. We knew 2021 revenue had to be £9m-£11m. So either way there isnt anything unexpected from a revenue perspective.

No mention of 2022 forecast, but hopefully we get more info on that in the next week.

STC medical looks interesting. What we dont know is whether the medical practitioners will be employed by DVRG or whether DVRG will refer users to external dermatologists for a commission. Either way, it opens up a avenue for those users who have skin conditions and want something doing about it. DVRG can clearly detect the issues they just can't provide the medical assistance... until now

Good posts all. I agree revenue guidance for 2022 must be in the region of £24m. I honestly cant imagine GB wanting to draw attention to the TP research note if he was about to release an RNS stating £13m or something like that.

He would be hung out to dry my some of the more critical posters here.

The TP research note is quite old now, so an RNS from the company locking in a forecast will have a much greater effect on the SP than a tweet from GB about a 5 month old research note, both of which wont have reach a wide audience